Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Globe Newswire•29/10/2026•08:30 ET
0
Key Highlights
- ➤Quoin (QNRX) will release Q3 2026 financial results before market open November 5, 2026
- ➤Corporate update will cover quarterly achievements, recent accomplishments, and financial highlights
- ➤Pipeline centers on QRX003 and QRX009 for rare and orphan diseases
ASHBURN, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to provide a corporate update and release its financial results for the third quarter ended September 30, 2026, before the market opens on Thursday, November 5, 2026.
The announcement will include an operational update highlighting key achievements from the quarter, recent accomplishments, and financial highlights from the third quarter of 2026.
Get started
Create a free account to read the full story.